Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05839392
NA
Novel Approaches to Target MECOM/EVI1 in AML
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
View on ClinicalTrials.gov
Summary
This is an academic, no-profit, multicenter, biological, non-pharmacologic study aimed at characterizing genome, transcriptome and proteome of patients affected by AML with MECOM or atypical 3q26 rearrangements.
Official title: Novel Approaches to Target MECOM/EVI1 in Acute Myeloid Leukemia
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2023-12-13
Completion Date
2026-12
Last Updated
2023-12-29
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
Biological characterization of AML with MECOM or atypical 3q26 rearrangements
Peripheral blood and bone marrow withdrawal
Locations (1)
Ematologia
Piacenza, Italy